Scott L. Rauch
Scott L. Rauch | |
---|---|
Nationality | American |
Alma mater | Amherst College, University of Cincinnati College of Medicine |
Known for | Research in anxiety disorders, neuroimaging |
Scientific career | |
Fields | Psychiatry, Neuroscience |
Institutions | McLean Hospital, Harvard Medical School |
Scott L. Rauch is an American psychiatrist and neuroscientist known for his research in anxiety disorders and neuroimaging. He is the President and Psychiatrist in Chief of McLean Hospital, a leading psychiatric hospital, and a Professor of Psychiatry at Harvard Medical School.
Education[edit | edit source]
Rauch received his undergraduate degree from Amherst College and his medical degree from the University of Cincinnati College of Medicine. He completed his residency in psychiatry at Massachusetts General Hospital.
Career[edit | edit source]
Rauch has held various academic and clinical positions throughout his career. He has been a prominent figure at McLean Hospital, where he has contributed significantly to the understanding and treatment of anxiety disorders through advanced neuroimaging techniques.
Research[edit | edit source]
Rauch's research primarily focuses on the neurobiological mechanisms underlying anxiety disorders. He has utilized various neuroimaging methods, including functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), to study brain function in individuals with these conditions.
Contributions[edit | edit source]
Rauch has published numerous articles in peer-reviewed journals and has been a key figure in advancing the field of psychiatry through his research. His work has helped to elucidate the neural circuits involved in anxiety disorders and has contributed to the development of new treatment approaches.
Affiliations[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD